CompanyGraph
What stands out
- Most companies in its industry are production businesses; this one is a sense-making business
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $15.36B, above the global median of $1.15B
- PositionReturn on equity is 77.3%, higher than 95% of its Diagnostics & Research peers (median 1.1%)
- Interpretations16 currently firing — 16
What this company is and how it runs — written from structure, not news.
What stands out
- Most companies in its industry are production businesses; this one is a sense-making business
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
15.36BUSDvs all stocks (USD)
Trailing P/E
33.90xvs Diagnostics & Research peers
Revenue (TTM)
2.68BUSDvs all stocks (USD)
Profit Margin
17.19%vs Diagnostics & Research peers
Beta
1.15xvs all stocks
52-Week Change
74.09%vs all stocks
Market Capitalization
15.36BUSDvs all stocks (USD)
Enterprise Value
14.86BUSDvs all stocks (USD)
Trailing P/E
33.90xvs Diagnostics & Research peers
Forward P/E
28.69xvs Diagnostics & Research peers
PEG Ratio
2.20xPrice to Sales (TTM)
5.74xvs Diagnostics & Research peers
Price to Book (MRQ)
25.68xvs Diagnostics & Research peers
Enterprise to Revenue
5.55xvs Diagnostics & Research peers
Enterprise to EBITDA
25.14xvs Diagnostics & Research peers
Gross Margin
27.78%vs Diagnostics & Research peers
Profit Margin
17.19%vs Diagnostics & Research peers
Operating Margin
20.03%vs Diagnostics & Research peers
Return on Assets (TTM)
17.47%vs Diagnostics & Research peers
Return on Equity (TTM)
77.25%vs Diagnostics & Research peers
Revenue (TTM)
2.68BUSDvs all stocks (USD)
Revenue per Share (TTM)
94.44USDUpdated Jul 19, 2026Quarterly Revenue Growth
26.50%vs Diagnostics & Research peers
Gross Profit (TTM)
1.93BUSDvs all stocks (USD)
EBITDA (TTM)
591.01MUSDvs all stocks (USD)
Net Income (TTM)
460.40MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
8.10%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
739.17MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
490.74MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Diagnostics & Research peers
Revenue
2.53BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
1.77BUSDFY2025 · Dec 31, 2025Gross Profit
760.62MUSDFY2025 · Dec 31, 2025Operating Income
534.93MUSDvs all stocks (USD)
Pre-tax Income
542.38MUSDFY2025 · Dec 31, 2025Income Tax Expense
91.25MUSDFY2025 · Dec 31, 2025Net Income
451.12MUSDFY2025 · Dec 31, 2025EBIT
534.93MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
570.79MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
197.56MUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
451.12MUSDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00USDFY2025 · Dec 31, 2025Operating Cash Flow
643.24MUSDFY2025 · Dec 31, 2025Free Cash Flow
611.88MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
497.05MUSDFY2025 · Dec 31, 2025Income Tax Paid
39.72MUSDFY2025 · Dec 31, 2025Interest Paid
0.00USDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
451.12MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
28.12MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
80.77MUSDFY2025 · Dec 31, 2025Stock-based Compensation
34.79MUSDFY2025 · Dec 31, 2025Other Non-cash Items
22.14MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-106.22MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
2.63MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
129.88MUSDFY2025 · Dec 31, 2025Capital Expenditures
-31.36MUSDFY2025 · Dec 31, 2025Other Investing Activity
216.00KUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-31.14MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
0.00USDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Common Stock Repurchase
-917.39MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-917.39MUSDFY2025 · Dec 31, 2025Shares Outstanding
28.56MSharesUpdated Jul 19, 2026Float Shares
23.00MSharesUpdated Jul 19, 2026Shares Short
2.13MSharesUpdated Jul 19, 2026Short Ratio
6.94daysvs all stocks
Short % of Shares Outstanding
9.23%vs all stocks
% Held by Insiders
19.43%vs all stocks
% Held by Institutions
87.08%vs all stocks
Total Cash (MRQ)
652.68MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
22.85USDUpdated Jul 19, 2026Total Debt (MRQ)
146.09MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.2442xvs Diagnostics & Research peers
Current Ratio (MRQ)
0.8470xvs Diagnostics & Research peers
Book Value per Share (MRQ)
20.95USDUpdated Jul 19, 2026Total Assets
1.98BUSDvs all stocks (USD)
Total Current Assets
989.62MUSDFY2025 · Dec 31, 2025Total Liabilities
1.52BUSDFY2025 · Dec 31, 2025Total Non-current Assets
985.85MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
172.65MUSDFY2025 · Dec 31, 2025Total Current Liabilities
1.34BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
497.05MUSDFY2025 · Dec 31, 2025Accounts Receivable
376.75MUSDFY2025 · Dec 31, 2025Accounts Payable
28.14MUSDFY2025 · Dec 31, 2025Deferred Revenue
854.39MUSDFY2025 · Dec 31, 2025Other Current Liabilities
52.83MUSDFY2025 · Dec 31, 2025Long-term Debt
113.64MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
57.66MUSDFY2025 · Dec 31, 2025Common Stock (Book)
284.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-459.98MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
459.07MUSDvs all stocks (USD)
Treasury Stock
12.16MUSDFY2025 · Dec 31, 202552-Week Low
306.70USDUpdated Jul 19, 202652-Week High
628.92USDUpdated Jul 19, 202652-Week Change
74.09%vs all stocks
Beta
1.15xvs all stocks
50-Day MA
472.56USDUpdated Jul 19, 2026200-Day MA
515.71USDUpdated Jul 19, 2026Avg 10-Day Volume
297.45KSharesUpdated Jul 19, 2026Avg 30-Day Volume
305.58KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
15.87USDUpdated Jul 19, 2026Other Income / Expense
-5.34MUSDFY2025 · Dec 31, 202516 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Diagnostic
High OCF-to-NI With Multi-Year Gross-Profit Growth and Elevated-Margin-With-Deceleration
Cash covers reported profit and gross profit is up, with margins high and growth slowing.
Reads
Three Asset-Base Ratios Elevated
It gets more sales from its assets than its industry does, and a lot of profit from them too.
Reads
Cash-Backed Growth Configuration
Revenue has grown steadily, and the cash arriving matches reported profit.
Reads
Cash Backing With OCF Coverage And Cash Near Total Debt
Cash on hand covers most or all of its total debt, and cash flow matches reported earnings.
Reads
Cash Backing With Revenue And Income Streaks
Revenue has risen in each of three years, profit in all three, and it holds more cash than debt.
Reads
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
Low Fixed-Asset Share With Elevated Turnover
It owns few buildings and machines, yet gets more sales and profit from its assets than its industry does.
Reads
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
Is this company growing?
Growth With Volume Backing
Revenue and net income have compounded over six years, and volume has leaned up with it.
Reads
Multi-Year Revenue And Profit Growth
Revenue and earnings have both grown steadily across six years.
Reads
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on equity is 77.3%, higher than 95% of its Diagnostics & Research peers (median 1.1%)Significant
Return on equity: 0.77Industry median: 0.01Industry P95: 0.30Peers compared: 31.00
Price-to-book is 25.68×, higher than 95% of its Diagnostics & Research peers (median 2.05×)Significant
Price-to-book: 25.68Industry median: 2.05Industry P95: 21.13Peers compared: 31.00
Structural Tensions
Most companies in its industry are production businesses; this one is a sense-making businessSignificant
Industry peers: 70.00Share on the common pattern %: 97.00
Financial Health
Altman Z-Score 7.71: safe zoneNotable
Altman Z-Score: 7.71
High earnings qualityNotable
Earnings Quality Score: 1.22
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $15.36B, above the global median of $1.15BNotable
Market cap (USD): 15,357,400,994Global Median: 1,146,734,693.424
Revenue is $2.68B, above the global median of $520.53MNotable
Revenue (USD): 2,678,267,904Global Median: 520,528,949.311
Levered free cash flow is $490.74M, above the global median of $16.24MNotable
Levered free cash flow (USD): 490,738,880Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Hangzhou Tigermed Consulting Co., Ltd.
Tier 1SenseMakingThroughput-Bound ConversionProductionFlow
Chengdu Yunda Technology Co. Ltd.
Tier 1SenseMakingThroughput-Bound ConversionInterfaceFlow
JC Finance & Tax Interconnect Co. Ltd.
Tier 1SenseMakingThroughput-Bound ConversionFlowRule
Materials Analysis Technology Inc.
Tier 1SenseMakingThroughput-Bound ConversionProductionRule
Tongyi Carbon Neutral Technology Co., Ltd.
Tier 1SenseMakingThroughput-Bound ConversionRuleRisk
Wuhan Kotei Informatics Co., Ltd.
Tier 1SenseMakingThroughput-Bound ConversionProductionFlow
Great Chinasoft Technology Co., Ltd.
Tier 1SenseMakingThroughput-Bound ConversionInterfaceFlow
Hefei Gocom Information Technology Co., Ltd.
Tier 1SenseMakingThroughput-Bound ConversionProductionFlow
YC Co., Ltd.
Tier 1SenseMakingThroughput-Bound ConversionInterfaceFlow
AB Dynamics plc
Tier 1SenseMakingThroughput-Bound ConversionProductionRule
Companies that share active interpretations — structural patterns currently present in both stocks.
NVIDIA Corporation
12 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash Backing With Revenue And Income StreaksFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedRevenue Growing With Receivables GrowingOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked Return on Capital ElevatedLow Fixed-Asset Share With Elevated TurnoverMulti-Year Revenue And Profit GrowthThree Asset-Base Ratios Elevated
Groupe Dynamite Inc.
11 interpretationsCash-Backed Growth ConfigurationCash Backing With Revenue And Income StreaksFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income GrowthHigh OCF-to-NI With Multi-Year Gross-Profit Growth and Elevated-Margin-With-DecelerationIndustry-Benchmarked Return on Capital ElevatedMulti-Year Revenue And Profit GrowthThree Asset-Base Ratios Elevated
Hammond Power Solutions Inc.
9 interpretationsROE, ROA, And Operating ROA ElevatedRevenue Growing With Receivables GrowingOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income GrowthGrowth With Volume BackingIndustry-Benchmarked Return on Capital ElevatedLow Fixed-Asset Share With Elevated TurnoverMulti-Year Revenue And Profit GrowthThree Asset-Base Ratios Elevated